ELIQUIS 5 mg/1 (Apixaban TABLET, FILM COATED) 5 mg/1

ELIQUIS 5 mg/1 is an oral medication containing apixaban, used for blood clotting prevention. This film-coated tablet is manufactured by E.R. Squibb & Sons, L.L.C. in the USA.

Strength

5 mg/1

Pack Size

10 BLISTER PACK in 1 CARTON (0003-0894-31) / 10 TABLET, FILM COATED in 1 BLISTER PACK

Manufacturer / TM Owner

E.R. Squibb & Sons, L.L.C.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ELIQUIS 5 mg/1 is commonly used to reduce the risk of blood clots in conditions like atrial fibrillation. It may also be prescribed for deep vein thrombosis or pulmonary embolism prevention. Apixaban is often used in patients undergoing knee or hip replacement surgery to prevent clotting. The primary use of ELIQUIS is to manage and prevent blood clots in various medical conditions.

Side Effects

Common effects of ELIQUIS 5 mg/1 may include bruising, bleeding, and nausea. Some users report dizziness or fatigue. These effects vary by individual and are not experienced by everyone. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

Handle ELIQUIS 5 mg/1 with care, especially if you have a history of bleeding disorders. Store the medication as directed and keep it out of reach of children. Follow the prescribed dosage and administration guidelines provided by your healthcare provider.

Avoid Interactions

ELIQUIS 5 mg/1 may interact with other medications, including blood thinners and certain antibiotics. Alcohol consumption should be moderated while using this medication. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

ELIQUIS 5 mg/1 is used to prevent blood clots in conditions like atrial fibrillation and after surgery.

Store ELIQUIS 5 mg/1 at room temperature, away from moisture and heat, and keep it out of reach of children.

Common side effects may include bruising, bleeding, nausea, dizziness, and fatigue.

Moderate alcohol consumption is advised while taking ELIQUIS 5 mg/1, as it may increase the risk of bleeding.

If you miss a dose, take it as soon as you remember, unless it is almost time for your next dose.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.